Andrew E. Singer, EVP & CFO at Epizyme, Inc. (EPZM), sold 2,026 shares at $9.57 ($20K) on 2016-05-09, disclosed to the SEC on 2016-05-12.
Open-market sale of $20k EPZM by EVP & CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.57 | 617 | $6K | 29.8% |
| 2 | $9.57 | 617 | $6K | 29.8% |
| 3 | $10.13 | 76 | $770 | 3.9% |
| 4 | $10.13 | 320 | $3K | 16.3% |
| 5 | $10.13 | 76 | $770 | 3.9% |
| 6 | $10.13 | 320 |
| $3K |
| 16.3% |
| Total | $9.79 avg | 2,026 | $20K | 100% |
| Filing → |
| EPZM | SELL | 2017-01-10 | $24K | — | Filing → |
| EPZM | SELL | 2016-12-12 | $11K | — | Filing → |
| EPZM | SELL | 2016-11-10 | $11K | — | Filing → |